The therapeutic experience reported in the paper was conceived after the use of nimotuzumab and radiotherapy (BSCPED-05 international multicentric trial, EUDRACT 2005-003100-11) in 2009 when we decided to explore the activity of the same combination plus vinorelbine (see the paper for the rationale).
Correction to: Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood / Massimino, Maura; Biassoni, Veronica; Miceli, Rosalba; Schiavello, Elisabetta; Warmuth-Metz, Monika; Modena, Piergiorgio; Casanova, Michela; Pecori, Emilia; Giangaspero, Felice; Antonelli, Manila; Buttarelli, Francesca Romana; Potepan, Paolo; Pollo, Bianca; Nunziata, Raffaele; Spreafico, Filippo; Podda, Marta; Anichini, Andrea; Clerici, Carlo Alfredo; Sardi, Iacopo; De Cecco, Loris; Bode, Udo; Bach, Ferdinand; Gandola, Lorenza. - In: JOURNAL OF NEURO-ONCOLOGY. - ISSN 0167-594X. - 138:3(2018), pp. 679-680. [10.1007/s11060-018-2893-6]
Correction to: Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood
Giangaspero, FeliceInvestigation
;Antonelli, ManilaInvestigation
;Buttarelli, Francesca Romana;
2018
Abstract
The therapeutic experience reported in the paper was conceived after the use of nimotuzumab and radiotherapy (BSCPED-05 international multicentric trial, EUDRACT 2005-003100-11) in 2009 when we decided to explore the activity of the same combination plus vinorelbine (see the paper for the rationale).| File | Dimensione | Formato | |
|---|---|---|---|
|
Massimino_Correction-to-Results_2018.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
512.68 kB
Formato
Adobe PDF
|
512.68 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
